Latest Agilent Technologies News & Updates

See the latest news and media coverage for Agilent. We track all announcements, press releases, and industry mentions in real time, all in one place.

Agilent Technologies (Agilent)

Manufacturer of analytical instruments and laboratory solutions

agilent.com

Headquarters: Santa Clara, United States
Founded year: 1999
Company type: Public company
Number of employees: 15,000+
Industry: Advanced Medical Equipment & Technology

Last updated Today

Latest news about Agilent Technologies (Agilent)

In short: Agilent reported strong Q2 2026 financial growth, completed its acquisition of Biocare Medical, and secured several key FDA and EU approvals.

Company announcements

July 23 Agilent

Agilent receives EU approval for PD-L1 test in ovarian cancer

The approval enables pathologists to identify patients who may be eligible for treatment with pembrolizumab, expanding companion diagnostic indications in the EU.

July 14 Agilent

Agilent receives FDA approval for PD-L1 IHC 28-8 pharmDx in ESCC and gastric cancers

The assay identifies PD-L1 expression in tumors, enabling treatment with nivolumab.

July 1 Agilent

Agilent launches AI-driven analysis module for xCELLigence RTCA eSight

The module simplifies label-free imaging analysis by reducing manual cell segmentation and parameter tuning.

June 25 Agilent

Agilent completes acquisition of Biocare Medical

The deal expands Agilent's pathology portfolio and is expected to be accretive in the first year.

Media coverage

July 23 GuruFocus

Agilent Technologies (A) Secures EU Certification for Key Diagno

On July 23, 2026, Agilent Technologies Inc (A) announced the attainment of European Union...

July 23 Yahoo Finance

Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Agilent Technologies Inc. (NYSE: A) today announced it has received European Union (EU) certification for PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic...

July 14 Yahoo Finance

Why Agilent Technologies (A) Is Up 5.4% After New FDA Nod For OPDIVO Cancer Test

In July 2026, Agilent Technologies received U.S. Food and Drug Administration approval for its PD-L1 IHC 28-8 pharmDx assay as a companion diagnostic to identify...

July 1 The Globe and Mail

Agilent (A) Receives a Buy from Jefferies

Detailed price information for Agilent Technologies (A-N) from The Globe and Mail including charting and trades.

Never miss news about Agilent

Track Agilent and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Agilent competitors & trending companies

Browse news for competitors to Agilent and other trending companies.